Randomized phase III trial comparing infused 5-fluorouracil/folinic acid (LV5FU) versus LV5FU+irinotecan (LV5FU+IRI) as adjuvant treatment after complete resection of liver metastases from colorectal cancer (LMCRC). (CPT-GMA-301)
M. Ychou, W. Hohenberger, S. Thezenas, M. Navarro, P. Gascon, C. Bokemeyer, E. Shacham-Shmueli, F. Rivera, C. Kwok-Keung Choi et A. Santoro
Journal of clinical oncology, Vol.26(15_suppl), pp.LBA4013-LBA4013
Randomized phase III trial comparing infused 5-fluorouracil/folinic acid (LV5FU) versus LV5FU+irinotecan (LV5FU+IRI) as adjuvant treatment after complete resection of liver metastases from colorectal cancer (LMCRC). (CPT-GMA-301)
Créateurs - sans rôle
M. Ychou
W. Hohenberger
S. Thezenas
M. Navarro
P. Gascon
C. Bokemeyer
E. Shacham-Shmueli
F. Rivera
C. Kwok-Keung Choi
A. Santoro
Détails de publication
Journal of clinical oncology, Vol.26(15_suppl), pp.LBA4013-LBA4013
Identifiants
99140167009311
Unité académique
Institut de Recherche en Cancérologie de Montpellier - IRCM